ILTS26-ABS-876NEOADJUVANT LENVATINIB COMBINED WITH LOCOREGIONAL THERAPY FOR DOWNSTAGING ADVANCED HEPATOCELLULAR CARCINOMA BEYOND MILAN CRITERIA IN TRANSPLANT-ELIGIBLE PATIENTS
Maen Abdelrahim, Abdelrahim:Section of Gastrointestinal Oncology,Houston Methodist Neal Cancer Center,Houston ,United States|Elsie Rizk:JC Walter Jr Center for Transplantation, Houston Methodist Hospital,Houston ,United States|Abdullah Esmail:Section of Gastrointestinal Oncology,Houston Methodist Neal Cancer Center,Houston ,United States|Zaina Alhawari:Section of Gastrointestinal Oncology,Houston Methodist Neal Cancer Center,Houston ,United States|Ashton Connor :JC Walter Jr Center for Transplantation, Houston Methodist Hospital,Houston ,United States|Sudha Kodali:JC Walter Jr Center for Transplantation, Houston Methodist Hospital,Houston ,United States|David W. Victor III:JC Walter Jr Center for Transplantation, Houston Methodist Hospital,Houston ,United States|Nakul Gupta:Section of Gastrointestinal Oncology,Houston Methodist Neal Cancer Center,Houston ,United States|Ashish Saharia:JC Walter Jr Center for Transplantation, Houston Methodist Hospital,Houston ,United States|Linda W Moore:JC Walter Jr Center for Transplantation, Houston Methodist Hospital,Houston ,United States|R. Mark Ghobrial:JC Walter Jr Center for Transplantation, Houston Methodist Hospital,Houston ,United States